# Delinieation of GIP's Effects During a Meal in Humans Using GIP Receptor Antagonisation (GA-4)

> **NCT03013296** · NA · COMPLETED · sponsor: **University Hospital, Gentofte, Copenhagen** · enrollment: 12 (actual)

## Conditions studied

- Glucose Metabolism Disorders

## Interventions

- **OTHER:** GIP-A
- **OTHER:** Placebo
- **OTHER:** GLP-1 receptor antagonist Exendin[9-39]
- **OTHER:** GIP-A + Exendin[9-39]

## Key facts

- **NCT ID:** NCT03013296
- **Lead sponsor:** University Hospital, Gentofte, Copenhagen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10
- **Primary completion:** 2017-07
- **Final completion:** 2018-09
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2019-06-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03013296

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03013296, "Delinieation of GIP's Effects During a Meal in Humans Using GIP Receptor Antagonisation (GA-4)". Retrieved via AI Analytics 2026-05-21 from https://api.ai-analytics.org/clinical/NCT03013296. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*